Literature DB >> 21252617

Upregulation of IL17RB during natural allergen exposure in patients with seasonal allergic rhinitis.

Yuri Matsumoto1, Emiko Noguchi, Yoshimasa Imoto, Kentaro Nanatsue, Kaoru Takeshita, Masanao Shibasaki, Tadao Arinami, Shigeharu Fujieda.   

Abstract

BACKGROUND: Seasonal allergic rhinitis (SAR) to Japanese cedar (Cryptomeria japonica; JC) is an IgE-mediated type I allergy affecting the nasal mucosa. However, the molecular mechanisms that underlie SAR are only partially understood. The aim of the study was to identify novel genes related to SAR during natural exposure to pollens, by using microarray analysis.
METHODS: Subjects were 32 SAR patients and 25 controls. Total RNA was extracted from CD4(+) T cells isolated from peripheral blood mononuclear cells and subjected to microarray analysis with Illumina Human Ref8 BeadChip arrays. The Mann-Whitney test was performed to identify genes whose expression was altered during allergen exposure. Quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) was performed on samples collected from SAR patients and controls to verify the microarray results.
RESULTS: Microarray analysis showed that the expression of 3 genes was significantly altered during allergen exposure. Among these 3 genes, the expression of interleukin 17 receptor beta (IL17RB) was confirmed to be upregulated in SAR patients compared to that of the IL17RB gene in healthy, non-allergic controls. The average fold change of IL17RB expression in the real-time RT-PCR experiment was 3.9 (P = 0.003).
CONCLUSIONS: The present study identified upregulation of IL17RB during natural allergen exposure in patients with SAR, which may further elucidate the molecular mechanisms underlying SAR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21252617     DOI: 10.2332/allergolint.10-OA-0230

Source DB:  PubMed          Journal:  Allergol Int        ISSN: 1323-8930            Impact factor:   5.836


  6 in total

1.  Transcriptional Profiling of Th2 Cells Identifies Pathogenic Features Associated with Asthma.

Authors:  Grégory Seumois; Jose Zapardiel-Gonzalo; Brandie White; Divya Singh; Veronique Schulten; Myles Dillon; Denize Hinz; David H Broide; Alessandro Sette; Bjoern Peters; Pandurangan Vijayanand
Journal:  J Immunol       Date:  2016-06-06       Impact factor: 5.422

2.  IL-4 Induces IL17Rb Gene Transcription in Monocytic Cells with Coordinate Autocrine IL-25 Signaling.

Authors:  Nathaniel M Weathington; Shreya M Kanth; Qiaoke Gong; James Londino; Akihiko Hoji; Mauricio Rojas; John Trudeau; Sally Wenzel; Rama K Mallampalli
Journal:  Am J Respir Cell Mol Biol       Date:  2017-09       Impact factor: 6.914

Review 3.  Role of innate lymphoid cells in allergic diseases.

Authors:  M Asghar Pasha; Gargi Patel; Russell Hopp; Qi Yang
Journal:  Allergy Asthma Proc       Date:  2019-05-01       Impact factor: 2.587

4.  A phenotypically and functionally distinct human TH2 cell subpopulation is associated with allergic disorders.

Authors:  Erik Wambre; Veronique Bajzik; Jonathan H DeLong; Kimberly O'Brien; Quynh-Anh Nguyen; Cate Speake; Vivian H Gersuk; Hannah A DeBerg; Elizabeth Whalen; Chester Ni; Mary Farrington; David Jeong; David Robinson; Peter S Linsley; Brian P Vickery; William W Kwok
Journal:  Sci Transl Med       Date:  2017-08-02       Impact factor: 17.956

5.  Cystatin SN upregulation in patients with seasonal allergic rhinitis.

Authors:  Yoshimasa Imoto; Takahiro Tokunaga; Yuri Matsumoto; Yuko Hamada; Mizuho Ono; Takechiyo Yamada; Yumi Ito; Tadao Arinami; Mitsuhiro Okano; Emiko Noguchi; Shigeharu Fujieda
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

6.  Genome-wide association study for pollinosis identified two novel loci in interleukin (IL)-1B in a Japanese population.

Authors:  Ryosuke Fujii; Asahi Hishida; Michael C Wu; Takaaki Kondo; Yuta Hattori; Mariko Naito; Kaori Endoh; Masahiro Nakatochi; Nobuyuki Hamajima; Michiaki Kubo; Kiyonori Kuriki; Kenji Wakai
Journal:  Nagoya J Med Sci       Date:  2018-02       Impact factor: 1.131

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.